Robert Hilkert

2.0k total citations
36 papers, 539 citations indexed

About

Robert Hilkert is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Robert Hilkert has authored 36 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Robert Hilkert's work include Blood Pressure and Hypertension Studies (19 papers), Heart Failure Treatment and Management (8 papers) and Heart Rate Variability and Autonomic Control (8 papers). Robert Hilkert is often cited by papers focused on Blood Pressure and Hypertension Studies (19 papers), Heart Failure Treatment and Management (8 papers) and Heart Rate Variability and Autonomic Control (8 papers). Robert Hilkert collaborates with scholars based in United States, Singapore and Switzerland. Robert Hilkert's co-authors include Nancy S. Redeker, Joseph L. Izzo, Bertram Pitt, Suzanne Oparil, John M. Flack, Scott D. Solomon, Akshay S. Desai, Thomas Quertermous, David A. Calhoun and Patrick Brunel and has published in prestigious journals such as Journal of the American College of Cardiology, Biochemistry and Annals of Surgery.

In The Last Decade

Robert Hilkert

35 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Hilkert United States	12	419	112	90	57	55	36	539
Ioannis Andrikou Greece	12	330 0.8×	120 1.1×	98 1.1×	36 0.6×	47 0.9×	55	540
Tonje A. Aksnes Norway	12	405 1.0×	165 1.5×	75 0.8×	29 0.5×	73 1.3×	30	541
C PORCELLATI Italy	8	428 1.0×	98 0.9×	55 0.6×	61 1.1×	56 1.0×	10	511
Е. И. Баранова Russia	11	290 0.7×	43 0.4×	65 0.7×	17 0.3×	155 2.8×	111	508
Kathleen M. Weil United States	8	242 0.6×	92 0.8×	272 3.0×	48 0.8×	112 2.0×	11	633
Francesca Negri Italy	19	886 2.1×	101 0.9×	95 1.1×	167 2.9×	42 0.8×	43	1.0k
Eiryu Sai Japan	12	174 0.4×	68 0.6×	98 1.1×	33 0.6×	45 0.8×	30	400
Esben Stistrup Lauritzen Denmark	8	130 0.3×	205 1.8×	43 0.5×	79 1.4×	28 0.5×	17	542
S PIERDOMENICO Italy	6	431 1.0×	168 1.5×	84 0.9×	31 0.5×	28 0.5×	9	566
Pierpaolo Tarzia Italy	12	373 0.9×	59 0.5×	174 1.9×	231 4.1×	19 0.3×	18	494

Countries citing papers authored by Robert Hilkert

Since Specialization

Citations

This map shows the geographic impact of Robert Hilkert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hilkert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hilkert more than expected).

Fields of papers citing papers by Robert Hilkert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Hilkert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hilkert. The network helps show where Robert Hilkert may publish in the future.

Co-authorship network of co-authors of Robert Hilkert

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Hilkert. A scholar is included among the top collaborators of Robert Hilkert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Hilkert. Robert Hilkert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dunbar, Sandra B., Xi Tan, Dominik Lautsch, et al.. (2023). The association between social determinants of health and patient‐centred outcomes in adults with heart failure with reduced ejection fraction. Journal of Advanced Nursing. 79(9). 3535–3548.

Khan, Muhammad Shahzeb, Haolin Xu, Gregg C. Fonarow, et al.. (2023). Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States. JACC Heart Failure. 11(2). 211–223. 10 indexed citations

Mentz, Robert J., et al.. (2021). Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction. Journal of Cardiac Failure. 28(8). 1349–1354. 10 indexed citations

Fendrick, A. Mark, Christie Teigland, Mei Yang, et al.. (2021). Out-of-pocket payments for part d covered medications by medicare fee-for-service beneficiaries with heart failure with reduced ejection fraction. American Heart Journal. 246. 74–81. 3 indexed citations

Mentz, Robert J., et al.. (2020). CHARACTERISTICS AND OUTCOMES OF HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS ENROLLED IN MEDICARE ADVANTAGE WITH AND WITHOUT RECENT WORSENING HEART FAILURE. Journal of the American College of Cardiology. 75(11). 809–809. 3 indexed citations

Cheng, Susan, Amil M. Shah, Juan Pablo Albisu, et al.. (2014). Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease. Journal of Hypertension. 32(12). 2479–2487. 20 indexed citations

Cheng, Susan, Carolyn S.P. Lam, Amil M. Shah, et al.. (2013). Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function. Journal of Hypertension. 32(1). 174–180. 3 indexed citations

Shah, Amil M., Carolyn S.P. Lam, Susan Cheng, et al.. (2011). The relationship between renal impairment and left ventricular structure, function, and ventricular–arterial interaction in hypertension. Journal of Hypertension. 29(9). 1829–1836. 22 indexed citations

Ofili, Elizabeth, Suzanne Oparil, Thomas D. Giles, et al.. (2011). Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. Journal of the American Society of Hypertension. 5(4). 249–258. 6 indexed citations

10.

Giles, Thomas D., Suzanne Oparil, Elizabeth Ofili, et al.. (2011). The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy. Blood Pressure Monitoring. 16(2). 87–95. 14 indexed citations

11.

Black, Henry R., et al.. (2011). Comparative Efficacy and Safety of Combination Aliskiren/Amlodipine and Amlodipine Monotherapy in African Americans With Stage 2 Hypertension. Journal of Clinical Hypertension. 13(8). 571–581. 18 indexed citations

12.

Oparil, Suzanne, Thomas D. Giles, Elizabeth Ofili, et al.. (2010). Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy. Journal of Hypertension. 29(1). 161–170. 9 indexed citations

13.

Black, Henry R., et al.. (2010). COMBINATION ALISKIREN+AMLODIPINE PROVIDES GREATER REDUCTIONS IN CLINIC AND 24-HOUR AMBULATORY BLOOD PRESSURES THAN AMLODIPINE ALONE IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION: PP.5.187. Journal of Hypertension. 28. e103–e104. 2 indexed citations

14.

Sowers, James R., Thomas D. Giles, Elizabeth Ofili, et al.. (2010). INTENSIVE TREATMENT WITH COMBINATION AMLODIPINE/VALSARTAN VS MODERATE THERAPY FOR HYPERTENSIVE PATIENTS WITH DIABETES OR CKD UNCONTROLLED ON ARB MONOTHERAPY: PP.17.149. Journal of Hypertension. 28. e295–e295. 1 indexed citations

15.

Izzo, Joseph L., et al.. (2009). Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension. Journal of Human Hypertension. 24(6). 403–409. 10 indexed citations

16.

Flack, John M., et al.. (2009). Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. Journal of Human Hypertension. 23(7). 479–489. 64 indexed citations

17.

Redeker, Nancy S. & Robert Hilkert. (2005). Sleep and Quality of Life in Stable Heart Failure. Journal of Cardiac Failure. 11(9). 700–704. 61 indexed citations

18.

Calvano, Steve E., Alan J. Spotnitz, Tyrone J. Krause, et al.. (2002). Alterations in Immunocyte Tumor Necrosis Factor Receptor and Apoptosis in Patients With Congestive Heart Failure. Annals of Surgery. 236(2). 254–260. 7 indexed citations

19.

Hilkert, Robert, et al.. (1993). Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor. Biochemistry. 32(31). 7932–7938. 52 indexed citations

20.

Hilkert, Robert, Mu-En Lee, & Thomas Quertermous. (1992). Genetic regulation of endothelin-1 in vascular endothelial cells. Trends in Cardiovascular Medicine. 2(4). 129–133. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact